ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS’ LVC market leadership with treatment for myopia, hyperopia, and mixed astigmatism. Jena, Germany / Dublin, USA | January 13, 2025 | Carl Zeiss Meditec AG ZEISS Medical Technology announced today that the MEL® 90 received approval from the U.S. Food and Drug Administration (FDA),…


